UB Paderborn / Katalog / Suche / in CDI

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.ES8-1-ES8-1

Faratian, D

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

European journal of cancer (1990), 2008-02, Vol.44 (3), p.391-399

2008

Link zum Volltext

Verfügbarkeit prüfen

Bronchial basal cell and epithelial repair

Thorax, 2004-08, Vol.59 (8), p.693-693

Faratian, D

2004

Link zum Volltext

Verfügbarkeit prüfen

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

International journal of gynecological cancer, 2006-04, Vol.16 (3), p.972-978

2006

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.60-60

2008

Link zum Volltext

Verfügbarkeit prüfen

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

European heart journal, 2013-08, Vol.34 (suppl 1), p.P5689-P5689

2013

Link zum Volltext

Verfügbarkeit prüfen

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Journal of obstetrics and gynaecology, 2006-05, Vol.26 (4), p.385-387

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-12

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-02-08

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-07-02

2010

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Annals of oncology, 2012-09, Vol.23, p.ix96

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-05-06

2010

Link zum Volltext

Verfügbarkeit prüfen

miRNA Profiling of Endocrine-Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5130-5130

2009

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5132-5132

2009

Link zum Volltext

Verfügbarkeit prüfen

Genes Regulated by miRNA in Endocrine-Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5149-5149

2009

Link zum Volltext

Verfügbarkeit prüfen

Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5055-5055

2011

Link zum Volltext

Verfügbarkeit prüfen

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

European journal of cancer supplements, 2007, Vol.5 (3), p.30-30

2007

Link zum Volltext

Verfügbarkeit prüfen

Rapid screening of tissue microarrays for Her-2 FISH testing is a safe, accurate, efficient and economic method enabling provision of an entirely FISH-based Her-2 testing service

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2070

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of letrozole and anastrozole on low ER expressing invasive breast carcinomas: results from a randomised trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.1065

2009

Link zum Volltext

Verfügbarkeit prüfen

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

Breast cancer research : BCR, 2008-01, Vol.10 (S2), p.P77-P77, Article P77

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized pre-operative study of 750 mg of fulvestrant and 20 mg tamoxifen in premenopausal women with estrogen receptor-positive breast cancer

European journal of cancer supplements, 2006-03, Vol.4 (2), p.150-151

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

European journal of cancer supplements, 2006-03, Vol.4 (2), p.81-82

2006

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab

Drugs of the future, 2008, Vol.33 (2), p.123

2008

Link zum Volltext

Verfügbarkeit prüfen

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Journal of Obstetrics and Gynaecology, 2006, Vol.26 (4), p.385-387

2006

Link zum Volltext

Verfügbarkeit prüfen

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Journal of visualized experiments, 2013-01 (71)

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

Bronchial basal cell and epithelial repair

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

miRNA Profiling of Endocrine-Resistant Breast Tumours

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Genes Regulated by miRNA in Endocrine-Resistant Breast Tumours

Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC)

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

Rapid screening of tissue microarrays for Her-2 FISH testing is a safe, accurate, efficient and economic method enabling provision of an entirely FISH-based Her-2 testing service

Effects of letrozole and anastrozole on low ER expressing invasive breast carcinomas: results from a randomised trial

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

Randomized pre-operative study of 750 mg of fulvestrant and 20 mg tamoxifen in premenopausal women with estrogen receptor-positive breast cancer

Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

Pertuzumab

Ovarian choriocarcinoma masquerading as ectopic pregnancy

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Aktive Filter

Suchergebnisse filtern